What is the most recent earnings date for ENTX stock?
ENTERA BIO LTD (ENTX) last reported earnings on 3/27/2026.
ENTERA BIO LTD (ENTX) Earnings History & Surprises
NASDAQ:ENTX • IL0011429839
Current stock price
1.17 USD
-0.02 (-1.68%)
At close:
1.2341 USD
+0.06 (+5.48%)
After Hours:
ENTX Earnings overview
Past quarterly earnings results for ENTERA BIO LTD (ENTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.15
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Mar 27, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.07
- EPS Surprise
- 23.75%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.07 | -0.09 | 23.75% | -16.67% | - | -100.00% | ||
| Q3 2025 | -0.07 | -0.09 | 23.75% | 12.50% | - | -100.00% | ||
| Q2 2025 | -0.06 | -0.11 | 46.52% | - | - | -100.00% | ||
| Q1 2025 | 0.06 | -0.07 | 184.03% | 220.00% | 40K | - | - | |
| Q4 2024 | -0.06 | -0.08 | 26.47% | 14.29% | 82K | 40.8K | 100.98% | - |
| Q3 2024 | -0.08 | -0.05 | -56.86% | - | 42K | 40.8K | 2.94% | - |
| Q2 2024 | -0.06 | -0.06 | 1.96% | 25.00% | 57K | - | - | |
| Q1 2024 | -0.05 | -0.06 | 18.30% | 37.50% | - | - | ||
| Q4 2023 | -0.07 | -0.08 | 14.22% | 30.00% | - | -100.00% | ||
| Q3 2023 | -0.08 | -0.09 | 12.85% | 27.27% | - | -100.00% | ||
| Q2 2023 | -0.08 | -0.07 | -12.04% | 27.27% | - | -100.00% | ||
| Q1 2023 | -0.08 | -0.12 | 34.64% | 38.46% | 102K | -100.00% | -100.00% | |
| Q4 2022 | -0.10 | -0.12 | 14.75% | 52.38% | 10K | 51K | -80.39% | -94.12% |
| Q3 2022 | -0.11 | -0.14 | 20.12% | -22.22% | 10K | 71.4K | -85.99% | -92.86% |
| Q2 2022 | -0.11 | -0.16 | 32.60% | 47.62% | 40K | 68.003K | -41.18% | -63.64% |
| Q1 2022 | -0.13 | -0.18 | 27.86% | -18.18% | 70K | 182.07K | -61.55% | -56.25% |
| Q4 2021 | -0.21 | -0.24 | 11.76% | -61.54% | 170K | 129.54K | 31.23% | -22.73% |
| Q3 2021 | -0.09 | -0.12 | 23.27% | - | 140K | 61.2K | 128.76% | 180.00% |
| Q2 2021 | -0.21 | -0.12 | -71.57% | -23.53% | 110K | 88.23K | 24.67% | 120.00% |
| Q1 2021 | -0.11 | -0.12 | 10.13% | - | 160K | 92.82K | 72.38% | 300.00% |
| Q4 2020 | -0.13 | -0.14 | 8.96% | - | 220K | - | - | |
| Q3 2020 | -0.09 | -0.20 | 55.88% | - | 50K | - | - | |
| Q2 2020 | -0.17 | -0.12 | -38.89% | - | 50K | - | - | |
| Q1 2020 | - | - | 40K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
70.19%
Max EPS beat (4)
184.03%
Min EPS beat (4)
23.75%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, ENTX has consistently beaten EPS estimates in all releases
In the last 4 quarters, ENTX has beaten the EPS estimates by 70.2% on average.
Related analysis
ENTERA BIO LTD / ENTX Earnings FAQ
Can you provide information on whether ENTERA BIO LTD beat earnings estimates in the last quarter?
ENTERA BIO LTD (ENTX) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often ENTERA BIO LTD beats earnings estimates?
In the last 4 quarters, ENTERA BIO LTD (ENTX) has beaten EPS estimates in 4 out of 4 releases.